Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc.; Outliers Inc. d/b/a Thesis Nootropics Inc. and Daniel Freed v. Recoop LLC and Anastasia Alt

District Court, S.D. New York·Decided December 30, 2025·No. 1:24-cv-01810·Unknown

Opinion

USDC SDNY DOCUMENT UNITED STATES DISTRICT COURT ELECTRONICALLY FILED SOUTHERN DISTRICT OF NEW YORK DOC #: monn nrc nanan KK DATE FILED:_12/30/2025 RECOOP LLC, : Plaintiff, : : 24-cv-01810 (LJL) -V- : : OPINION AND ORDER OUTLIERS INC. d/b/a THESIS : NOOTROPICS INC., : Defendant. :

OUTLIERS INC. d/b/a THESIS : NOOTROPICS INC. and DANIEL : FREED, : Counterclaim and : Third-Party Plaintiffs. : -v- : RECOOP LLC and ANASTASIA ALT, : Counterclaim and : Third-Party Defendants. :

wn eK LEWIS J. LIMAN, United States District Judge: Third-Party Plaintiff Daniel Freed (“Freed”) moves, pursuant to Federal Rule of Civil Procedure 56, for an order granting him partial summary judgment against Third-Party Defendant Recoop LLC (“Recoop”) and confirming the Final Award, dated May 16, 2025, together with the Interim Award, dated January 21, 2025 (collectively, the “Award”), rendered in an arbitration (the “Arbitration”) before the Honorable Billie Colombaro (Ret.) of the American Arbitration Association (“AAA”). Dkt. No. 168.

BACKGROUND Familiarity with the prior proceedings in this matter is presumed. On March 8, 2024, Recoop initiated this action against Defendant Outliers Inc. d/b/a Thesis Nootropics Inc. (“Thesis”), alleging claims under the federal Defend Trade Secrets Act (“DTSA”), 18 U.S.C. §§ 1836 et seq., the federal Wiretap Act, 18 U.S.C. §§ 2510 et seq., and the California Invasion

of Privacy Act, Cal. Penal Code §§ 630–638, and for unfair competition and unjust enrichment. Dkt. No. 1. Thesis answered the complaint on May 24, 2024. Dkt. No. 13. It also filed a counterclaim against Recoop and Anastasia Alt (“Alt”), the CEO and co-founder of Recoop. Id. at 14–33 (“Countercl.”); Countercl. ¶¶ 19, 22. In addition, Freed, the CEO of Thesis and a former co-founder, member, officer and employee of Recoop, Countercl. ¶ 1, filed a third-party complaint against Recoop and Alt for defamation, breach of contract, and tortious interference with prospective business relations and seeking a declaratory judgment regarding the rights and obligations of Recoop and Freed under a separation agreement they entered into on February 29, 2020, id. ¶ 9. Freed and Recoop are parties to the Recoop LLC Limited Liability Company Agreement

dated February 27, 2019 (the “LLC Agreement”). Id. ¶ 26; Dkt. No. 13-1. The LLC Agreement contains an indemnification provision: The LLC shall, to the fullest and broadest extent permitted by law, indemnify and hold harmless each agent . . . against losses and damages arising out of liabilities or expenses incurred by him as a result of serving in the capacity by reason of which such Person is deemed to be an “agent” pursuant to this subsection (a), regardless of whether the agent is or continues to be a Member, Manager or Officer at the time any such liability or expense is paid. Dkt. No. 13-1 ¶ 12.1. The LLC Agreement also contains an arbitration clause. It provides in pertinent part: Any controversy, dispute, or claim arising out of, in connection with, or in relation to the interpretation, performance or breach of this Agreement . . . , including, without limitation, any claim based on contract, tort, or statute, shall be resolved or determined, at the request of any party, by arbitration conducted in New York, NY, in accordance with the then-existing Rules for Commercial Arbitration of the American Arbitration Association. Any judgment or award rendered by the arbitrator will be final, binding and non-appealable, and judgment may be entered by any State or Federal court having jurisdiction thereof. Id. ¶ 14.10. On June 7, 2024, Freed and Thesis filed a complaint and demand for arbitration with the AAA against Recoop, seeking a declaration that Freed was contractually entitled to advancement of his expenses and to indemnification by Recoop for the defense costs of this action. Dkt. No. 168 ¶¶ 1–2; Dkt. No. 169 ¶¶ 1–2. A hearing in the arbitration was held before retired Judge Colombaro on January 7, 2025. Dkt. No. 169 ¶ 6. Freed and Alt testified. Id. On January 21, 2025, the AAA issued an interim award, ordering that Freed was entitled to an advancement from Recoop for the legal expenses and costs he incurred defending himself and his actions in this lawsuit. Dkt. No. 168-2 at 6.1 The arbitrator also concluded that Thesis 0F was not entitled to an advancement. Id. On February 14, 2025, the arbitrator issued a further interim award, ordering that Recoop pay Freed $380,190.75 for advancement no later than five business days from the date of the award. Id. at 10. The arbitrator issued an amended interim award on March 4, 2025, suspending the payment deadline for the February 14, 2025 interim award so that the arbitrator could determine the proper amount of an advancement in light of the filing of Freed’s counterclaims. Id. at 15. Treating Alt’s objections to the February 14, 2025 interim award as a motion for reconsideration, the arbitrator issued another interim award on April 2, 2025, confirming the

1 Citations to this docket entry use ECF pagination. February 14, 2025 interim award and awarding Freed an advancement in the amount of $380,190.75. Id. at 17–18. In this case, on April 14, 2025, the Court issued an order granting summary judgment to Thesis on all of the claims in Recoop’s First Amended Complaint. Dkt. No. 108.2 1F On May 19, 2025, the arbitrator issued the Final Award which is dated May 16, 2025. Dkt. No. 168-2 at 20–25. The arbitrator ordered: Mr. Freed is entitled to indemnification and reimbursement of all legal fees and expenses incurred resulting from his having to defend himself in the underlying litigation and in this Arbitration, including but not limited to “expert witness expenses” and fees/expenses incurred in this final phase in the arbitration. Id. at 25. The arbitrator referenced the prior determination that Freed was entitled to advancement in the amount of $380,190.75. Id. at 21. The arbitrator also ordered that Recoop was responsible for the AAA’s administrative fees of $18,575.00 and the arbitrator’s compensation, totaling $17,105.00, and directed that Recoop reimburse Freed the sum of $14,802.50 in fees previously incurred and paid by Freed. Id. at 25. On October 10, 2025, Freed moved for leave to file an amended third-party claim seeking to confirm the Interim Award and the Final Award. Dkt. No. 153. The Court granted that motion on November 11, 2025. Dkt. No. 159.3 2F Freed filed his amended third-party complaint on November 18, 2025. Dkt. No. 163. Alt and Recoop answered the third-party complaint on December 2, 2025. Dkt. No. 167. On

2 On June 28, 2024, Recoop filed a First Amended Complaint asserting claims under the DTSA and federal Wiretap Act along with state-law claims. Dkt. No. 19. On July 3, 2024, Thesis filed an Amended Answer and Counterclaims against Recoop and Alt, and Freed filed third-party claims against Recoop and Alt. Dkt. No. 23. 3 The Court also denied the motion of Alt and Recoop to dismiss the claims of Freed and Thesis for lack of subject matter jurisdiction. Dkt. No. 159 at 3–8. December 5, 2025, Freed filed this motion for partial summary judgment. Dkt. No. 168. The motion is supported by a memorandum of law in support of the motion, the affidavit of Lauren Rayner Davis, a Rule 56.1 statement, and exhibits. Id. Recoop filed a response on December 19, 2025. Dkt. No. 169. On December 26, 2025, Freed filed a reply memorandum of law in

further support of the motion for partial summary judgment. Dkt. No. 171.

Free access — add to your briefcase to read the full text and ask questions with AI

Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc.; Outliers Inc. d/b/a Thesis Nootropics Inc. and Daniel Freed v. Recoop LLC and Anastasia Alt, (S.D.N.Y. 2025).

Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc.; Outliers Inc. d/b/a Thesis Nootropics Inc. and Daniel Freed v. Recoop LLC and Anastasia Alt (Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc.; Outliers Inc. d/b/a Thesis Nootropics Inc. and Daniel Freed v. Recoop LLC and Anastasia Alt) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Florasynth, Inc. v. Alfred Pickholz
750 F.2d 171 (Second Circuit, 1984)
Ottley v. Schwartzberg
819 F.2d 373 (Second Circuit, 1987)
Barbier v. Shearson Lehman Hutton Inc.
948 F.2d 117 (Second Circuit, 1991)
Schwartz v. Merrill Lynch & Co.
665 F.3d 444 (Second Circuit, 2011)
Blair & Co., Inc. v. Gottdiener
462 F.3d 95 (Second Circuit, 2006)
Zeiler v. Deitsch
500 F.3d 157 (Second Circuit, 2007)
Zurich American Insurnce v. Team Tankers A.S.
811 F.3d 584 (Second Circuit, 2016)
Pike v. Freeman
266 F.3d 78 (Second Circuit, 2001)
Eisenhauer v. Culinary Institute of America
84 F.4th 507 (Second Circuit, 2023)